Hypercoagulability and ischemic stroke in young patients;Estados de hipercoagulabilidad e ictus isquémico en pacientes jóvenes

Neurologia

Volumn 25, Issue 6, 2010, Pages 343-348

  Martinez Martinez M ^a   Cazorla Garcia R ^a   Rodriguez de Antonio L A ^a   Martinez Sanchez P ^a   Fuentes, B ^a   Diez Tejedor, E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

Cryptogenic stroke; Hypercoagulability; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; DIHYDROFOLATE REDUCTASE; LUPUS ANTICOAGULANT; METHYLTETRAHYDROFOLATE REDUCTASE; PROTEIN C; PROTEIN S; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; STROKE; THROMBOCYTOSIS; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS; STROKE; THROMBOPHILIA;

EID: 77955280447     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2009.01.001     Document Type: Article

References (23)

1. Sánchez-Martín B., Grasa J.M., Latorre A., Montañés M.A., García-Erce J.A., Torres M., et al. Acquired and inherited hypercoagulability among patients with cerebral venous thrombosis. Neurología. 2002, 17:405-409.
2. Tripodi A., Mahucci M. Laboratory investigation of thrombophilia. Clinical Chemistry. 2001, 47:1547-1606.
3. Markus H., Hambley H. Neurology and the blood: haematological abnormalities in ischaemic stroke. J Neurol Neurosurg Psychiatry. 1998, 64:150-159.
4. Levine S.R. Hypercoagulable states and stroke: a selective review. CNS Spectr. 2005, 10:567-578.
5. Kittner S.J., Stern B.J., Wozniak M., Buchholz D.W., Earley C.J., Feeser B.R., et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998, 50:890-894.
6. Becker S., Heller C.H., Gropp F., Scharrer I., Kreuz W. Thrombophilic disorders in children with cerebral infarction. Lancet. 1998, 352:1756-1757.
7. Arboix A., Díaz J. Ictus: tipos etiológicos y criterios diagnósticos. Guía para el diagnóstico y tratamiento del ictus 2006, 1-25. Prous Science, Barcelona. Díez-Tejedor (Ed.).
8. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8 Suppl 7:19-28.
9. Sacco S., Carolei A. Homocysteine and stroke: another brick in the wall. Cli Sci (Lond). 2009, 118:183-185.
10. Kahn M.J. Hypercoagulability as a cause of stroke in adults. South Med J. 2003, 96:350-353.
11. Ropper A.H., Brown R.H. Enfermedades vasculares cerebrales. Principios de neurología 2007, 709. Mc Graw-Hill Interamericana, México DF.
12. Simioni P., Ronde H., Prandoni P., Saladini M., Bertina R.M., Girolami A. Ischemic stroke in young patients with activated protein C resistance. Stroke. 1995, 26:885-890.
13. Martínez-Sánchez P., Fuentes Gimeno B., Oliver Ruiz J.M., Ortega-Casarrubios M.A., Idrovo Freire L., Díez-Tejedor E. Migraine and interatrial septal abnormalities in patients under 55 with cryptogenic stroke. Med Clin (Barc). 2008, 131:521-525.
14. Bushnell C., Goldstein L.B. Screening for hypercoagulable syndromes following stroke. South Med J. 2003, 96:350-353.
15. Rahemtullah A., Van Cott E.M. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med. 2007, 131:890-901.
16. Bushnell C.D., Goldstein L.B. Diagnostic testing fir coagulopathies in patients with isquemic stroke. Stroke. 2000, 31:3067-3078.
17. Tatlisumak T., Fisher M. Hematologic disorders associated with isquemic stroke. J Neurol Sci. 1996, 140:1-11.
18. Haywood S., Liesner R., Pindora S., Ganesan V. Thrombophilia and first arterial ischaemic stroke: a systematic review. Ach Dis Child. 2005, 90:402-405.
19. Leno C., Berciano J., Combarros O., Polo J.M., Pascual J., Quintana F., et al. A prospective study of stroke in young adults in Cantabria, Spain. Stroke. 1993, 24:792-795.
20. Rodriguez-Castellano E., Ríos-Blanco J.J., Robles-Marhuenda A., Gil-Aguado A., Soto-Abánades C., Pérez-Valero I., et al. Ictus and antiphospholipid syndrome: how much is enough?. Autoimmunity. 2008, 4:140-142.
21. Guidelines for the prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006; 37:577-617.
22. Guercini F., Acciaresi M., Paciaroni M. Cryptogenic Stroke: time to determine a etiology. J Thromb Haemost. 2008, 6:549-554.
23. Putaala J., Metso A.J., Metso T.M., Konkola N., Kraemer Y., Haapaniemi E., et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke. The Helsinki Young Stroke Registry. Stroke. 2009, 40:1195-1203.